Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027807 · ClinicalTrials.gov registry record · Phase 1
Biological Therapy in Treating Women With Stage IV Breast Cancer
A Phase 1 study, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00027807: Completed Phase 1 study, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT00027807 is a Phase 1 study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00027807, a Phase 1 study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combining different biological therapies in treating women who have stage IV breast cancer.
Interventions
- BIOLOGICAL Aldesleukin
- BIOLOGICAL Sargramostim
- BIOLOGICAL therapeutic autologous lymphocytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2001-10 |
| Est. Completion | 2013-03 |
| Phase | Phase 1 |
What the finished NCT00027807 record still lists
NCT00027807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which Aldesleukin is the first listed.
NCT00027807 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00027807 about?
NCT00027807 is a clinical study titled "Biological Therapy in Treating Women With Stage IV Breast Cancer". RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combining different biological therapies in trea...
What is the current status of trial NCT00027807?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2001-10. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00027807?
The interventions under investigation include: Aldesleukin (BIOLOGICAL), Sargramostim (BIOLOGICAL), therapeutic autologous lymphocytes (BIOLOGICAL).
Who is sponsoring clinical trial NCT00027807?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00027807's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia